An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
- PMID: 19150980
- PMCID: PMC2658096
- DOI: 10.1074/jbc.M900301200
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
Erratum in
-
Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.J Biol Chem. 2020 Feb 28;295(9):2886. doi: 10.1074/jbc.AAC120.012837. Epub 2020 Feb 28. J Biol Chem. 2020. PMID: 32111721 Free PMC article. No abstract available.
Abstract
The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival. Rapamycin is a potent allosteric mTORC1 inhibitor with clinical applications as an immunosuppressant and anti-cancer agent. Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin. Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy. These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1. Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.
Figures
Similar articles
-
Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.J Biol Chem. 2010 Dec 3;285(49):38362-73. doi: 10.1074/jbc.M110.141168. Epub 2010 Oct 11. J Biol Chem. 2010. PMID: 20937815 Free PMC article.
-
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038. PLoS Biol. 2009. PMID: 19209957 Free PMC article.
-
Relieving autophagy and 4EBP1 from rapamycin resistance.Mol Cell Biol. 2011 Jul;31(14):2867-76. doi: 10.1128/MCB.05430-11. Epub 2011 May 16. Mol Cell Biol. 2011. PMID: 21576371 Free PMC article.
-
Targeting mTOR globally in cancer: thinking beyond rapamycin.Cell Cycle. 2009 Dec;8(23):3831-7. doi: 10.4161/cc.8.23.10070. Epub 2009 Dec 14. Cell Cycle. 2009. PMID: 19901542 Review.
-
Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.Adv Biol Regul. 2022 Jan;83:100854. doi: 10.1016/j.jbior.2021.100854. Epub 2021 Dec 6. Adv Biol Regul. 2022. PMID: 34996736 Review.
Cited by
-
Ribosome rescue factor PELOTA modulates translation start site choice for C/EBPα protein isoforms.Life Sci Alliance. 2024 May 21;7(7):e202302501. doi: 10.26508/lsa.202302501. Print 2024 Jul. Life Sci Alliance. 2024. PMID: 38803235 Free PMC article.
-
The Metabolic and Lipidomic Fingerprint of Torin1 Exposure in Mouse Embryonic Fibroblasts Using Untargeted Metabolomics.Metabolites. 2024 Apr 25;14(5):248. doi: 10.3390/metabo14050248. Metabolites. 2024. PMID: 38786725 Free PMC article.
-
eIF4A1 enhances LARP1-mediated translational repression during mTORC1 inhibition.Nat Struct Mol Biol. 2024 May 21. doi: 10.1038/s41594-024-01321-7. Online ahead of print. Nat Struct Mol Biol. 2024. PMID: 38773334
-
Maximum entropy determination of mammalian proteome dynamics.Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2313107121. doi: 10.1073/pnas.2313107121. Epub 2024 Apr 23. Proc Natl Acad Sci U S A. 2024. PMID: 38652742
-
Relationship of mTORC1 and ferroptosis in tumors.Discov Oncol. 2024 Apr 7;15(1):107. doi: 10.1007/s12672-024-00954-w. Discov Oncol. 2024. PMID: 38583115 Free PMC article. Review.
References
-
- Guertin, D. A., and Sabatini, D. M. (2007) Cancer Cell 12 9-22 - PubMed
-
- Sehgal, S. N. (2003) Transplant. Proc. 35 S7-S14 - PubMed
-
- Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L., and Sabatini, D. M. (2006) Mol. Cell 22 159-168 - PubMed
-
- Richter, J. D., and Sonenberg, N. (2005) Nature 433 477-480 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous